Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Umar-Farouk Mamani"'
Publikováno v:
Biomolecules, Vol 13, Iss 3, p 448 (2023)
Liver fibrosis is the excessive accumulation of extracellular matrix (ECM) in the liver due to chronic injuries and inflammation. These injuries activate and transform quiescent hepatic stellate cells (HSCs) into proliferative myofibroblast-like cell
Externí odkaz:
https://doaj.org/article/f7c4315fc32b4fb1919b521c0f154947
Autor:
John Fetse, Zhen Zhao, Hao Liu, Umar-Farouk Mamani, Bahaa Mustafa, Pratik Adhikary, Mohammed Ibrahim, Yanli Liu, Pratikkumar Patel, Maryam Nakhjiri, Mohammed Alahmari, Guangfu Li, Kun Cheng
Publikováno v:
Journal of Medicinal Chemistry. 65:12002-12013
Blockade of the interaction between programmed cell death ligand-1 (PD-L1) and its receptor PD-1 has shown great success in cancer immunotherapy. Peptides possess unique characteristics that give them significant advantages as immune checkpoint inhib
Publikováno v:
Trends in Pharmacological Sciences.
Autor:
Mohammed Alahmari, Umar-Farouk Mamani, Yuhan Guo, Chien-Yu Lin, Mohammed Nurudeen Ibrahim, Yongren Li, Kun Cheng
Publikováno v:
Cancer Research. 83:LB194-LB194
Lymphocyte activation gene-3 (LAG-3) has emerged as a promising target for cancer immunotherapy. It is expressed on activated CD4+ and CD8+ T cells, and on the surface of B cells, natural killer cells, and dendritic cells (DC). It has also been found
Publikováno v:
Cancer Research. 83:5183-5183
Lung cancer is one of the leading causes of cancer death and the second most cancer in the world. Compared to systematic administration, local delivery of therapeutic agents to the lung increases their accumulation in lung cancer cells and reduces th
Autor:
Umar-Farouk Mamani, Yanli Liu, Sashi Kandel, Nurudeen Mohammed Ibrahim, Chien Yu Lin, Siyuan Hao, Kun Cheng, Pratik Adhikary, Yongren Li, Evanthia Omoscharka, Bahaa Mustafa, John Peter Fetse, Jianming Qiu
Publikováno v:
Advanced Therapeutics. 4:2170016
Autor:
Siyuan Hao, Nurudeen Mohammed Ibrahim, Pratik Adhikary, Yanli Liu, Yongren Li, John Peter Fetse, Sashi Kandel, Kun Cheng, Chien Yu Lin, Umar-Farouk Mamani, Jianming Qiu, Evanthia Omoscharka, Bahaa Mustafa
Publikováno v:
Advanced Therapeutics
COVID‐19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which infects host cells by binding its viral spike protein receptor‐binding domain (RBD) to the angiotensin converting enzyme 2 (ACE2) on host cells. Blo